Company intelligence / Profile preview

Margarita's

Lexington, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Margarita Therapeutics is an early-stage biotechnology company focused on developing novel therapeutic modalities for oncology and rare genetic disorders. The company leverages a proprietary platform designed to optimize the delivery and efficacy of mRNA-based drugs and small molecule inhibitors. By targeting previously undruggable pathways, Margarita Therapeutics aims to provide transformative treatments for patients with high unmet medical needs. The company is currently advancing its lead programs through pre-clinical validation and IND-enabling studies.

Therapeutic areas: OncologyRare Diseases
Modalities: Small moleculemRNA-based drugsBiologic
Industry: Biotech

Beyond the preview

Go deeper on Margarita's.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Margarita's.

Explore the full profile